FOLLOWUS
1.Department of Oncology, the Third Affiliated Hospital of Hunan University of Chinese Medicine, Zhuzhou (412000),Hunan Province, China
2.Department of Oncology, the First Affiliated Hospital of Hunan College of Traditional Chinese Medicine, Zhuzhou (412000), Hunan Province, China
3.Hunan Provincial Key Laboratory for the Prevention and Treatment of Ophthalmology and Otolaryngology Diseases with Traditional Chinese Medicine, Hunan University of Chinese Medicine,Changsha (410208), China
Prof. PENG Qing-hua, E-mail: pqh410007@126.com
纸质出版日期:2022-08,
网络出版日期:2021-11-09,
录用日期:2021-05-17
Scan for full text
Yue-jun LI, Lin-li LIAO, Pei LIU, 等. 四君子汤通过降低β-catenin转录活性抑制胃癌肿瘤干细胞干性[J]. Chinese Journal of Integrative Medicine, 2022,28(8):702-710.
Yue-jun LI, Lin-li LIAO, Pei LIU, et al. Sijunzi Decoction Inhibits Stemness by Suppressing β-Catenin Transcriptional Activity in Gastric Cancer Cells[J]. Chinese Journal of Integrative Medicine, 2022,28(8):702-710.
Yue-jun LI, Lin-li LIAO, Pei LIU, 等. 四君子汤通过降低β-catenin转录活性抑制胃癌肿瘤干细胞干性[J]. Chinese Journal of Integrative Medicine, 2022,28(8):702-710. DOI: 10.1007/s11655-021-3314-9.
Yue-jun LI, Lin-li LIAO, Pei LIU, et al. Sijunzi Decoction Inhibits Stemness by Suppressing β-Catenin Transcriptional Activity in Gastric Cancer Cells[J]. Chinese Journal of Integrative Medicine, 2022,28(8):702-710. DOI: 10.1007/s11655-021-3314-9.
目的:
2
探讨四君子汤对胃癌细胞的抑制作用及分子机制.
方法:
2
MKN74和MKN45是两种具有干细胞性质的CD44阳性胃癌细胞系. 将细胞分为治疗组及对照组. 治疗组给予四君子汤水提醇沉物(1-5 mg/mL)治疗
疗程48 h-14 d. 对照组给予等体积的磷酸盐缓冲盐水治疗. 采用细胞计数试剂盒8 (CCK-8) 法测定细胞活力. 通过克隆成球实验和胃癌肿瘤干细胞标记物表达检测胃癌肿瘤干细胞干性. 采用核质分离实验和染色质免疫共沉淀法分别测定四君子汤水提醇沉物处理后β-catenin的细胞内分布和DNA结合活性.
结果:
2
四君子汤水提醇沉物抑制MKN74和MKN45细胞株的生长并诱导其凋亡(
P
<
0.05). 四君子汤水提醇沉物可明显抑制胃癌细胞克隆成球能力和胃癌肿瘤干细胞标记物的表达(
P
<
0.05). 在分子机制上
β-catenin是维持胃癌肿瘤干细胞干性的关键调控因子. 四君子汤水提醇沉物科明显降低β-catenin的细胞核内聚集和DNA结合活性(
P
<
0.05).
结论:
2
四君子汤通过降低β-catenin转录活性
抑制胃癌肿瘤干细胞干性.
Objective:
2
To investigate a previously uncharacterized function of Sijunzi Decoction (SJZD) in inhibition of gastric cancer stem cells (GCSCs).
Methods:
2
MKN74 and MKN45
two CD44 positive gastric cancer cell lines with stem cell properties were used. The cells were divided into 2 groups. Treatment group was treated with SJZD (1–5 mg/mL) for indicated time (48 h–14 days). The control group was treated with equal volume of phosphate buffered saline. Cell Counting Assay Kit-8 were used to measure cell viability. Spheroid colony formation and GCSCs marker expression were performed to determine GCSCs stemness. Cell fractionation and chromatin immunoprecipitation assays were used to assess the distribution and DNA-binding activity of β-catenin after SJZD treatment
respectively.
Results:
2
SJZD treatment repressed cell growth and induced apoptosis in MKN74 and MKN45 cell lines (
P
<
0.05). Moreover
SJZD dramatically inhibited formation of spheroid colony and expression of GCSC markers in GC cells (
P
<
0.05). Mechanistically
SJZD reduced nuclear accumulation and DNA binding activity of β-catenin (
P
<
0.05)
the key regulator for maintaining CSC stemness.
Conclusion:
2
SJZD inhibits GCSCs by attenuating the transcriptional activity of β-catenin.
Sijunzi DecoctionChinese medicinegastric cancercancer stem cellsβ-catenin
Guo JH, Chen G, Yang SQ, Wei MH, Chen X. Clinical observation of the role of Chenxia Sijunzi Decoction in promoting the recovery of gastrointestinal function in critically ill patients. Chin Crit Care Med (Chin) 2012;24:674-676.
Liu L, Han L, Wong DY, Yue PY, Ha WY, Hu YH, et al.Effects of Si-Jun-Zi Decoction polysaccharides on cell migration and gene expression in wounded rat intestinal epithelial cells. Br J Nutr 2005;93:21-29.
Zhong WR, Huang YX, Cui JP. Clinical study on modified Sijunzi Decoction in treating intestinal metaplasia of gastric mucosa. Chin J Integr Tradit West Med (Chin)1997;17:462-464.
Chen GZ, Fu D. Effect of Jiawei Sijunzi Decoction on migrating myoelectric complex in 8 Gy irradiated rats. Chin J Integr Tradit West Med (Chin) 1996;16:221-223.
Liu Y, Yang J, Cai Z. Chemical investigation on Sijunzi Decoction and its two major herbs Panax ginseng and Glycyrrhiza uralensis by LC/MS/MS. J Pharm Biomed Anal 2006;41:1642-1647.
Wang L, Jiang Q, Hu J, Zhang Y, Li J. Research progress on chemical constituents of Lonicerae japonicae flos.Biomed Res Int 2016;2016:8968940.
Jie Y, He W, Yang X, Chen W. Kruppel-like factor 4 acts as a potential therapeutic target of Sijunzi Decoction for treatment of colorectal cancer. Cancer Gene Ther 2017;24:361-366.
Jia J, Qin Y, Zhang L, Guo C, Wang Y, Yue X, et al.Sijunzi Decoction-treated rat serum induces apoptosis of side population cells in gastric carcinoma. Exp Ther Med 2018;15:1718-1727.
Chen L, Jin T, Ning C, Wang S, Wang L, Lin J. Anti-tumor and immune-modulating effect of Jiawei Sijunzi Decoction in mice bearing hepatoma H22 tumor. J Southern Med Univ(Chin) 2019;39:241-248.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J,Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
Park JY, von Karsa L, Herrero R. Prevention strategies for gastric cancer: a global perspective. Clin Endosc 2014;47:478-489.
Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH,Jones DL, et al. Cancer stem cells–perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-9344.
Yang YC, Wang SW, Hung HY, Chang CC, Wu IC, Huang YL, et al. Isolation and characterization of human gastric cell lines with stem cell phenotypes. J Gastroenterol Hepatol 2007;22:1460-1468.
Gong X, Azhdarinia A, Ghosh SC, Xiong W, An Z, Liu Q,et al. LGR5-targeted antibody-drug conjugate eradicates gastrointestinal tumors and prevents recurrence. Mol Cancer Ther 2016;15:1580-1590.
Nguyen PH, Giraud J, Staedel C, Chambonnier L, Dubus P,Chevret E, et al. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth. Oncogene 2016;35:5619-5628.
Shitara K, Doi T, Nagano O, Imamura CK, Ozeki T,Ishii Y, et al. Dose-escalation study for the targeting of CD44v(+) cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205). Gastric Cancer 2017;20:341-349.
Bekaii-Saab T, El-Rayes B. Identifying and targeting cancer stem cells in the treatment of gastric cancer. Cancer 2017;123:1303-1312.
Holland JD, Klaus A, Garratt AN, Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 2013;25:254-264.
White BD, Chien AJ, Dawson DW. Dysregulation of Wnt/beta-catenin signaling in gastrointestinal cancers.Gastroenterology 2012;142:219-232.
MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling:components, mechanisms, and diseases. Dev Cell 2009;17:9-26.
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
Ibrahim EE, Babaei-Jadidi R, Saadeddin A, Spencer-Dene B, Hossaini S, Abuzinadah M, et al. Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms. Stem Cells 2012;30:2076-2087.
Lee SH, Koo BS, Kim JM, Huang S, Rho YS, Bae WJ, et al. Wnt/beta-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. J Pathol 2014;234:99-107.
Amable G, Martinez-Leon E, Picco ME, Di Siervi N, Davio C, Rozengurt E, et al. Metformin inhibits beta-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells. Int J Biochem Cell Biol 2019;112:88-94.
Yong X, Tang B, Xiao YF, Xie R, Qin Y, Luo G, et al.Helicobacter pylori upregulates Nanog and Oct4 via Wnt/beta-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. Cancer Lett 2016;374:292-303.
Zhang J, Huang K, Shi Z, Zou J, Wang Y, Jia Z, et al. High beta-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Neur Oncol 2011;13:600-609.
Takaishi S, Okumura T, Tu S, Wang SS, Shibata W,Vigneshwaran R, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009;27:1006-1020.
Lu Y, Li L, Zhang JW, Zhong XQ, Wei JA, Han L. Total polysaccharides of the Sijunzi Decoction attenuate tumor necrosis factor-alpha-induced damage to the barrier function of a Caco-2 cell monolayer via the nuclear factor-kappaB-myosin light chain kinase-myosin light chain pathway. World J Gastroenterol 2018;24:2867-2877.
Li Y, Gong L, Qi R, Sun Q, Xia X, He H, et al. Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression. Drug Des Devel Ther 2017;11:2481-2491.
Gong L, Liu F, Xiong Z, Qi R, Luo Z, Gong X, et al.Heterochromatin protects retinal pigment epithelium cells from oxidative damage by silencing p53 target genes. Proc Natl Acad Sci U S A 2018;115:E3987-E3995.
Guan Z, Wang M, Cai Y, Yang H, Zhao M, Zhao C. Rapid characterization of the chemical constituents of Sijunzi Decoction by UHPLC coupled with fourier transform ion cyclotron resonance mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2018;1086:11-22.
Xu Q, Yu H, Wu H, Gong L, Pan Y, Qiu Y. Simultaneous determination of four components in Sijunzi Decoction by HPLC. Chin J Exp Tradit Med Formulae (Chin) 2013;19:62-65.
Karimian A, Ahmadi Y, Yousefi B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair 2016;42:63-71.
Morata-Tarifa C, Jimenez G, Garcia MA, Entrena JM,Grinan-Lison C, Aguilera M, et al. Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells. Sci Rep 2016;6:18772.
Amaral RLF, Miranda M, Marcato PD, Swiech K.Comparative analysis of 3D bladder tumor spheroids obtained by forced floating and hanging drop methods for drug screening. Front Physiol 2017;8:605.
Tian T, Zhang Y, Wang S, Zhou J, Xu S. Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer. J Biomed Res 2012;26:336-345.
Hutz K, Mejias-Luque R, Farsakova K, Ogris M, Krebs S,Anton M, et al. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells.Carcinogenesis 2014;35:942-950.
Harkonen K, Oikari S, Kyykallio H, Capra J, Hakkola S,Ketola K, et al. CD44s assembles hyaluronan coat on filopodia and extracellular vesicles and induces tumorigenicity of MKN74 gastric carcinoma cells. Cells 2019;8:276-295
Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J,Nika H, et al. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem 2007;282:11221-11229.
Li CC, Le K, Kato J, Moss J, Vaughan M. Enhancement of beta-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals. Proc Natl Acad Sci U S A 2016;113:5946-5951.
Reya T, Clevers H. Wnt signalling in stem cells and cancer.Nature 2005;434:843-850.
Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells:an evolving concept. Nat Rev Cancer 2012;12:133-143.
Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, et al. Wnt/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol 2017;10:101.
0
浏览量
8
Downloads
0
CSCD
关联资源
相关文章
相关作者
相关机构